These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 26100684)

  • 1. The Experience Sampling Method--a new digital tool for momentary symptom assessment in IBS: an exploratory study.
    Mujagic Z; Leue C; Vork L; Lousberg R; Jonkers DM; Keszthelyi D; Hesselink MA; van Schagen TJ; van Os J; Masclee AA; Kruimel JW
    Neurogastroenterol Motil; 2015 Sep; 27(9):1295-302. PubMed ID: 26100684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Experience Sampling Method-Evaluation of treatment effect of escitalopram in IBS with comorbid panic disorder.
    Vork L; Mujagic Z; Drukker M; Keszthelyi D; Conchillo JM; Hesselink MAM; van Os J; Masclee AAM; Leue C; Kruimel JW
    Neurogastroenterol Motil; 2019 Jan; 31(1):e13515. PubMed ID: 30460734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rome III vs Rome IV criteria for irritable bowel syndrome: A comparison of clinical characteristics in a large cohort study.
    Vork L; Weerts ZZRM; Mujagic Z; Kruimel JW; Hesselink MAM; Muris JWM; Keszthelyi D; Jonkers DMAE; Masclee AAM
    Neurogastroenterol Motil; 2018 Feb; 30(2):. PubMed ID: 28804974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results From a Psychometric Validation Study: Patients With Irritable Bowel Syndrome Report Higher Symptom Burden Using End-of-Day Vs Real-Time Assessment.
    Bosman M; Vork L; Jonkers D; Snijkers J; Topan R; Aziz Q; Midenfjord I; Simren M; Masclee A; Keszthelyi D;
    Am J Gastroenterol; 2024 Sep; ():. PubMed ID: 39311432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-Specific Stress-Abdominal Pain Interaction in Irritable Bowel Syndrome: An Exploratory Experience Sampling Method Study.
    Vork L; Keszthelyi D; van Kuijk SMJ; Quetglas EG; Törnblom H; Simrén M; Aziz Q; Corsetti M; Tack J; Mujagic Z; Leue C; Kruimel JW; Masclee AAM
    Clin Transl Gastroenterol; 2020 Jul; 11(7):e00209. PubMed ID: 32764210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of episodes of irritable bowel syndrome using ecological momentary assessment.
    Weinland SR; Morris CB; Hu Y; Leserman J; Bangdiwala SI; Drossman DA
    Am J Gastroenterol; 2011 Oct; 106(10):1813-20. PubMed ID: 21647206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The temporal relationship of daily life stress, emotions, and bowel symptoms in irritable bowel syndrome-Diarrhea subtype: A smartphone-based experience sampling study.
    Chan Y; So SH; Mak ADP; Siah KTH; Chan W; Wu JCY
    Neurogastroenterol Motil; 2019 Mar; 31(3):e13514. PubMed ID: 30450780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development, content validity, and cross-cultural adaptation of a patient-reported outcome measure for real-time symptom assessment in irritable bowel syndrome.
    Vork L; Keszthelyi D; Mujagic Z; Kruimel JW; Leue C; Pontén I; Törnblom H; Simrén M; Albu-Soda A; Aziz Q; Corsetti M; Holvoet L; Tack J; Rao SS; van Os J; Quetglas EG; Drossman DA; Masclee AAM
    Neurogastroenterol Motil; 2018 Mar; 30(3):. PubMed ID: 29106029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Digital Instruments for Reporting of Gastrointestinal Symptoms in Clinical Trials: Comparison of End-of-Day Diaries Versus the Experience Sampling Method.
    Beckers AB; Snijkers JTW; Weerts ZZRM; Vork L; Klaassen T; Smeets FGM; Masclee AAM; Keszthelyi D
    JMIR Form Res; 2021 Nov; 5(11):e31678. PubMed ID: 34821561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of post-infectious irritable bowel syndrome and functional intestinal disorders following a water-borne viral gastroenteritis outbreak.
    Zanini B; Ricci C; Bandera F; Caselani F; Magni A; Laronga AM; Lanzini A;
    Am J Gastroenterol; 2012 Jun; 107(6):891-9. PubMed ID: 22525306
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Markers for visceral hypersensitivity in patients with irritable bowel syndrome.
    Ludidi S; Mujagic Z; Jonkers D; Keszthelyi D; Hesselink M; Kruimel J; Conchillo J; Masclee A
    Neurogastroenterol Motil; 2014 Aug; 26(8):1104-11. PubMed ID: 24920528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patients suspected of irritable bowel syndrome--cross-sectional study exploring the sensitivity of Rome III criteria in primary care.
    Engsbro AL; Begtrup LM; Kjeldsen J; Larsen PV; de Muckadell OS; Jarbøl DE; Bytzer P
    Am J Gastroenterol; 2013 Jun; 108(6):972-80. PubMed ID: 23419383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-time Symptom Assessment in Patients With Endometriosis: Psychometric Evaluation of an Electronic Patient-Reported Outcome Measure, Based on the Experience Sampling Method.
    van Barneveld E; Lim A; van Hanegem N; van Osch F; Vork L; Kruimel J; Bongers M; Leue C
    JMIR Form Res; 2023 Mar; 7():e29480. PubMed ID: 36867439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychometric evaluation of an experience sampling method-based patient-reported outcome measure in functional dyspepsia.
    Klaassen T; Smeets FGM; Vork L; Tack J; Talley NJ; Simrén M; Aziz Q; Ford AC; Kruimel JW; Conchillo JM; Leue C; Masclee AAM; Keszthelyi D
    Neurogastroenterol Motil; 2021 Sep; 33(9):e14136. PubMed ID: 33934444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea.
    Talley NJ; Dennis EH; Schettler-Duncan VA; Lacy BE; Olden KW; Crowell MD
    Am J Gastroenterol; 2003 Nov; 98(11):2454-9. PubMed ID: 14638348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are bowel symptoms and psychosocial features different in irritable bowel syndrome patients with abdominal discomfort compared to abdominal pain?
    Fang XC; Fan WJ; Drossman DD; Han SM; Ke MY
    World J Gastroenterol; 2022 Sep; 28(33):4861-4874. PubMed ID: 36156921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A combined nutrient and lactulose challenge test allows symptom-based clustering of patients with irritable bowel syndrome.
    Le Nevé B; Posserud I; Böhn L; Guyonnet D; Rondeau P; Tillisch K; Naliboff B; Mayer EA; Simrén M
    Am J Gastroenterol; 2013 May; 108(5):786-95. PubMed ID: 23588235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No difference in symptoms of irritable bowel syndrome between healthy subjects and patients with recurrent depression in remission.
    Karling P; Danielsson A; Adolfsson R; Norrback KF
    Neurogastroenterol Motil; 2007 Nov; 19(11):896-904. PubMed ID: 17973640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychological comorbidity and complexity of gastrointestinal symptoms in clinically diagnosed irritable bowel syndrome patients.
    Mikocka-Walus A; Turnbull D; Moulding N; Wilson I; Andrews JM; Holtmann G
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1137-43. PubMed ID: 18070012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastrointestinal-specific anxiety: an important factor for severity of GI symptoms and quality of life in IBS.
    Jerndal P; Ringström G; Agerforz P; Karpefors M; Akkermans LM; Bayati A; Simrén M
    Neurogastroenterol Motil; 2010 Jun; 22(6):646-e179. PubMed ID: 20367800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.